Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Near Infrared Spectroscopy (NIRS) for Assessment of Depression

NCT: NCT04061148 · RECRUITING

NCT IDNCT04061148
StatusRECRUITING
Start Date2019-01-04
Completion2030-12-30
SponsorUniversity of California, San Francisco (OTHER)
First posted
Last updated

Brief Summary

Develop a NIRSIT testing protocol that can be administered in the diagnostic setting and reliably distinguishes the symptoms and severity of depression, with the help of repeated measure (up to five visits per subject) comparison of patients being treated for Major Depressive Disorder with control, non-depressed subjects.

Frequently Asked Questions

What is Near Infrared Spectroscopy (NIRS) for Assessment of Depression?

Near Infrared Spectroscopy (NIRS) for Assessment of Depression is a clinical trial registered under NCT04061148. Current status: RECRUITING.

What is the status of NCT04061148?

The current status of NCT04061148 (Near Infrared Spectroscopy (NIRS) for Assessment of Depression) is: RECRUITING.

When did Near Infrared Spectroscopy (NIRS) for Assessment of Depression start?

Near Infrared Spectroscopy (NIRS) for Assessment of Depression started on 2019-01-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.